Website & contact details
- Website
Caltag Medsystems Limited
- Incorporated
- 16 February 2001 (25 years)
- Industry
- Manufacture of medical and dental instruments and supplies (32500) Other research and experimental development on natural sciences and engineering (72190)Other professional, scientific and technical activities n.e.c. (74909)
- Accounts type
- Total exemption full
- Region
- South East
- Address
- Whiteleaf Business Centre 11 Little BalmerBuckingham Industrial EstateBuckinghamMK18 1TF
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 20 March 2027
- Last conf. stmt
- 6 March 2026
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 26 November 2025
British
Born November 1957
British
Born February 1983 (43)
Director · Appointed 11 May 2001
British
Born August 1954 (72)
Officer history (5 former)
26 November 2025
26 November 2025
Resigned Almond, Penelope Jane, Mrs. as Director
26 November 2025
19 August 2024
1 March 2004
29 February 2004
29 February 2004
Resigned Ray, Clare Elizabeth as Secretary
20 March 2002
Resigned Spencer, Emma as Director
11 May 2001
11 May 2001
16 February 2001
Appointed Spencer, Emma as Director
16 February 2001
Appointed Ray, Clare Elizabeth as Secretary
16 February 2001
Appointed Almond, Penelope Jane, Mrs. as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 10 October 2025
Owns 75–100% of shares
Holds 75–100% of voting rights
Limited By Guarantee
Reg. no. 16684111
Former controllers (1)
10 October 2025
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Caltag Medsystems Limited This company Owns 75–100% of shares
Cytomark Limited Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2025 · total exemption full accounts
- Net Assets
- £516,368
- Cash
- £446,229
- Employees
- 16
- Debt Ratio
- 40%
- Current Ratio
- 2.1x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fixed Assets | £147,329 | £53,336 | £57,408 | £43,287 | £72,193 | £115,186 | £158,916 |
| Current Assets | £716,156 | £933,259 | £814,193 | £803,298 | £862,230 | £880,790 | £838,243 |
| Cash | £446,229 | £642,025 | £666,989 | £428,489 | £561,681 | £467,877 | £424,468 |
| Creditors (< 1 year) | £341,830 | £351,082 | £263,758 | £280,489 | £271,469 | £307,127 | £376,513 |
| Creditors (> 1 year) | £30,749 | £40,182 | |||||
| Net Current Assets | £374,326 | £582,177 | £550,435 | £522,809 | £590,761 | £573,663 | £461,730 |
| Net Assets | £516,368 | £599,417 | £562,360 | £560,795 | £652,347 | £666,077 | £597,874 |
| Shareholder Funds | £516,368 | £599,417 | £562,360 | £560,795 | £652,347 | £666,077 | £597,874 |
What Caltag Medsystems say about themselves
“Caltag Medsystems is a European distributor of diagnostic and research reagents for cell biology, flow cytometry, immunology, histology and neuroscience. We offer over 300,000 high quality products at competitive prices.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 30 July 2026 | Total exemption full accounts | 31 December 2025 | ||
| 6 March 2026 | Confirmation statement with updates | 6 March 2026 | ||
| 2 February 2026 | Confirmation statement with updates | 21 January 2026 | ||
| 27 November 2025 | Appointment of a director | |||
| 26 November 2025 | Termination of appointment of a secretary |
Some other companies at this address
Other companies in this industry
Loughborough
Orwell
Rochdale
Swindon
Borehamwood
Debenham
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →